𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)

✍ Scribed by Höpfner, M; Sutter, A P; Gerst, B; Zeitz, M; Scherübl, H


Book ID
109997799
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
242 KB
Volume
89
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Targeted inhibition of the epidermal gro
✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (‘Iressa’), an orally a

Expression and regulation of the novel v
✍ Alexander A. Parikh; Wen Biao Liu; Fan Fan; Oliver Stoeltzing; Niels Reinmuth; C 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

## Abstract ## BACKGROUND It was recently shown that neuropilin‐1 (NRP‐1), which was described originally as a receptor for the semaphorins/collapsins (ligands involved in neuronal guidance), is a coreceptor for vascular endothelial growth factor (VEGF) and increases the affinity of specific isofo

Cytotoxic effects induced by a combinati
✍ Murielle Mimeault; Erik Moore; Nicolas Moniaux; Jean-Pierre Hénichart; Patrick D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 552 KB

## Abstract Although the blockade of the hedgehog cascade by using cyclopamine has been reported to inhibit the growth of some cancer cell types, few studies on the mechanism by which this drug alone or in combination with other cytotoxic agents induces its cytotoxic effect have been reported. In o